FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216156700> ?p ?o ?g. }

• W3216156700 endingPage "669" @default.
• W3216156700 startingPage "661" @default.
• W3216156700 abstract "The use of direct factor Xa inhibitors rivaroxaban and apixaban (XABANs) has rapidly increased; however, there is no validated test available to monitor the effect on hemostasis. This study aims to assess how hemostatic management based on the Rapid Thromboelastography (R-TEG) variable activated clotting time (ACT) of XABAN patients with ongoing bleedings or in need for acute surgical intervention, affected patient outcome. A total of 343 XABAN patients were included in the main analysis together with 50 healthy volunteers to validate the reference value for ACT. An ACT >120 s (s) was defined as having XABAN-induced coagulopathy. Sixty-five percent of the XABAN patients presented with R-TEG ACT within the normal reference. Patients with XABAN-induced coagulopathy had a significantly increased risk of severe bleeding. Significantly more patients with extra-cerebral bleeding (ECB) and ACT above 120 s were transfused with five red blood cell (RBC) units or more compared to patients with ACT at 120 s or below (17% vs. 3%, p <.05). Significantly more XABAN-patients with ACT above 120 s received pro-hemostatic intervention with prothrombin complex concentrate (PCC) when compared to those with ACT at 120 s or below (ECB: 2% vs. 8%, p =.03, intracranial hemorrhage: 25% vs. 68%, p <.00). Patients who received PCC had a higher 30- and 90-day mortality compared to the rest of the cohort (16% vs. 6%, p = .02 and 21% vs. 7%, p =.00). Patients with XABAN-induced coagulopathy as evaluated by R-TEG ACT presented with more severe bleeding and higher transfusion requirements when compared to those with ACT in the normal range. This suggests that R-TEG ACT measurement in XABAN patients with active hemorrhage or in need for acute surgery may be of clinical value." @default.
• W3216156700 created "2021-12-06" @default.
• W3216156700 creator A5015807294 @default.
• W3216156700 creator A5015899682 @default.
• W3216156700 creator A5040176601 @default.
• W3216156700 creator A5054142495 @default.
• W3216156700 creator A5073195590 @default.
• W3216156700 date "2021-11-22" @default.
• W3216156700 modified "2023-09-24" @default.
• W3216156700 title "Managing patients on direct factor Xa inhibitors with rapid thrombelastography" @default.
• W3216156700 cites W1591205163 @default.
• W3216156700 cites W1995801614 @default.
• W3216156700 cites W2031581415 @default.
• W3216156700 cites W2077008458 @default.
• W3216156700 cites W2080423166 @default.
• W3216156700 cites W2087002320 @default.
• W3216156700 cites W2092158875 @default.
• W3216156700 cites W2110823555 @default.
• W3216156700 cites W2152623033 @default.
• W3216156700 cites W2194419520 @default.
• W3216156700 cites W2323138975 @default.
• W3216156700 cites W2332156797 @default.
• W3216156700 cites W2511296650 @default.
• W3216156700 cites W2567289819 @default.
• W3216156700 cites W2568964326 @default.
• W3216156700 cites W2771087973 @default.
• W3216156700 cites W2889256743 @default.
• W3216156700 cites W2891946521 @default.
• W3216156700 cites W2892153557 @default.
• W3216156700 cites W2896296125 @default.
• W3216156700 cites W2904680572 @default.
• W3216156700 cites W2914381505 @default.
• W3216156700 cites W2932976565 @default.
• W3216156700 cites W2943229452 @default.
• W3216156700 cites W3020215883 @default.
• W3216156700 doi "https://doi.org/10.1080/00365513.2021.2003855" @default.
• W3216156700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34807769" @default.
• W3216156700 hasPublicationYear "2021" @default.
• W3216156700 type Work @default.
• W3216156700 sameAs 3216156700 @default.
• W3216156700 citedByCount "3" @default.
• W3216156700 countsByYear W32161567002022 @default.
• W3216156700 crossrefType "journal-article" @default.
• W3216156700 hasAuthorship W3216156700A5015807294 @default.
• W3216156700 hasAuthorship W3216156700A5015899682 @default.
• W3216156700 hasAuthorship W3216156700A5040176601 @default.
• W3216156700 hasAuthorship W3216156700A5054142495 @default.
• W3216156700 hasAuthorship W3216156700A5073195590 @default.
• W3216156700 hasConcept C126322002 @default.
• W3216156700 hasConcept C141071460 @default.
• W3216156700 hasConcept C16124881 @default.
• W3216156700 hasConcept C2776301958 @default.
• W3216156700 hasConcept C2777091921 @default.
• W3216156700 hasConcept C2777664302 @default.
• W3216156700 hasConcept C2777987278 @default.
• W3216156700 hasConcept C2778205648 @default.
• W3216156700 hasConcept C2778382381 @default.
• W3216156700 hasConcept C2778589496 @default.
• W3216156700 hasConcept C2778661090 @default.
• W3216156700 hasConcept C2779161974 @default.
• W3216156700 hasConcept C2779936836 @default.
• W3216156700 hasConcept C2780434524 @default.
• W3216156700 hasConcept C2780638905 @default.
• W3216156700 hasConcept C2910686401 @default.
• W3216156700 hasConcept C42219234 @default.
• W3216156700 hasConcept C71924100 @default.
• W3216156700 hasConceptScore W3216156700C126322002 @default.
• W3216156700 hasConceptScore W3216156700C141071460 @default.
• W3216156700 hasConceptScore W3216156700C16124881 @default.
• W3216156700 hasConceptScore W3216156700C2776301958 @default.
• W3216156700 hasConceptScore W3216156700C2777091921 @default.
• W3216156700 hasConceptScore W3216156700C2777664302 @default.
• W3216156700 hasConceptScore W3216156700C2777987278 @default.
• W3216156700 hasConceptScore W3216156700C2778205648 @default.
• W3216156700 hasConceptScore W3216156700C2778382381 @default.
• W3216156700 hasConceptScore W3216156700C2778589496 @default.
• W3216156700 hasConceptScore W3216156700C2778661090 @default.
• W3216156700 hasConceptScore W3216156700C2779161974 @default.
• W3216156700 hasConceptScore W3216156700C2779936836 @default.
• W3216156700 hasConceptScore W3216156700C2780434524 @default.
• W3216156700 hasConceptScore W3216156700C2780638905 @default.
• W3216156700 hasConceptScore W3216156700C2910686401 @default.
• W3216156700 hasConceptScore W3216156700C42219234 @default.
• W3216156700 hasConceptScore W3216156700C71924100 @default.
• W3216156700 hasIssue "8" @default.
• W3216156700 hasLocation W32161567001 @default.
• W3216156700 hasLocation W32161567002 @default.
• W3216156700 hasOpenAccess W3216156700 @default.
• W3216156700 hasPrimaryLocation W32161567001 @default.
• W3216156700 hasRelatedWork W2017845046 @default.
• W3216156700 hasRelatedWork W2043126212 @default.
• W3216156700 hasRelatedWork W2075273329 @default.
• W3216156700 hasRelatedWork W2076919074 @default.
• W3216156700 hasRelatedWork W2106973647 @default.
• W3216156700 hasRelatedWork W2295828145 @default.
• W3216156700 hasRelatedWork W2416524516 @default.
• W3216156700 hasRelatedWork W2602066139 @default.
• W3216156700 hasRelatedWork W2896296125 @default.

• next